NATCOPHARM2018-01-012018-03-31in-bse-fin:OneOperatingExpenses01Member NATCOPHARM2018-01-012018-03-31in-bse-fin:OneOperatingExpenses02Member NATCOPHARM2018-01-012018-03-31in-bse-fin:FourOperatingExpenses01Member NATCOPHARM2018-01-012018-03-31in-bse-fin:FourOperatingExpenses02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares NATCOPHARM 2017-04-01 2018-03-31 2018-05-16 INR Millions Yearly Single segment PHARMACEUTICALS 2018-01-01 2018-03-31 Unaudited Standalone 7290000000.00 206000000.00 7496000000.00 1075000000.00 21000000.00 92000000.00 1060000000.00 27000000.00 178000000.00 1279000000.00 3732000000.00 3764000000.00 0.00 3764000000.00 1082000000.00 -279000000.00 803000000.00 0.00 2961000000.00 0.00 0.00 0.00 0.00 2961000000.00 -40000000.00 2921000000.00 0.00 0.00 369000000.00 2 16.05 16.01 0.00 0.00 16.05 16.01 2017-04-01 2018-03-31 Audited Standalone 21085000000.00 394000000.00 21479000000.00 3905000000.00 227000000.00 -247000000.00 3122000000.00 147000000.00 655000000.00 4794000000.00 12603000000.00 8876000000.00 0.00 8876000000.00 2173000000.00 -279000000.00 1894000000.00 0.00 6982000000.00 0.00 0.00 0.00 0.00 6982000000.00 -47000000.00 6935000000.00 0.00 0.00 369000000.00 2 30885000000.00 39.38 39.24 0.00 0.00 39.38 39.24 Excise Duty 0.00 Other Expenses 1279000000.00 Excise Duty 172000000.00 Other Expenses 4622000000.00 0.00 0.00 0.00